Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1977 Feb 1;145(2):275–292. doi: 10.1084/jem.145.2.275

T-cell-mediated concomitant immunity to syngeneic tumors. I. Activated macrophages as the expressors of nonspecific immunity to unrelated tumors and bacterial parasites

PMCID: PMC2180603  PMID: 401860

Abstract

Progressive growth of the SA1 sarcoma was shown to result in the generation of a state of concomitant resistance to growth of a second implant of the same tumor. The responding lymph nodes of concomitantly immune mice were shown to contain theta-positive T cells that could specifically neutralize the growth of tumor cells in a normal test recipient. Nevertheless, the concomitantly immune host itself was capable to a limited extent of suppressing the growth of unrelated tumors. The generation of immunity, moreover, was associated with the generation of a powerful state of macrophage-mediated, nonspecific resistance to the bacterial parasite, Listeria monocytogenes. It was concluded that systemic macrophage activation was the consequence of the generation of T-cell-mediated immunity to the progressively growing tumor, and that this not only gave the host the capacity to inhibit the growth of unrelated tumors, but also to protect itself against microbial infection. The results gives credence to the view that macrophages play a central role in defense against microbial and neoplastic growth.

Full Text

The Full Text of this article is available as a PDF (1.0 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BASES R. E., KRAKOFF I. H. ENHANCED RETICULOENDOTHELIAL PHAGOCYTIC ACTIVITY IN MYELOPROLIFERATIVE DISEASES. J Reticuloendothel Soc. 1965 May;2:1–7. [PubMed] [Google Scholar]
  2. Baldwin R. W. In vitro assays of cell-mediated immunity to human solid tumors: problems of quantitation, specificity, and interpretation. J Natl Cancer Inst. 1975 Oct;55(4):745–748. doi: 10.1093/jnci/55.4.745. [DOI] [PubMed] [Google Scholar]
  3. Blamey R. W., Crosby D. L., Baker J. M. Reticuloendothelial activity during the growth of rat sarcomas. Cancer Res. 1969 Feb;29(2):335–337. [PubMed] [Google Scholar]
  4. Burdick J. F., Wells S. A., Jr Cross-reactivity between cell-surface antigens of different murine carcinogen-induced tumors, demonstrated by a modified isotopic antiglobulin test. J Natl Cancer Inst. 1973 Oct;51(4):1149–1156. doi: 10.1093/jnci/51.4.1149. [DOI] [PubMed] [Google Scholar]
  5. Chen M. G., Schooley J. C. Effects of ionizing radiation and vinblastine on the proliferation of peritoneal macrophage precursors in the mouse. Radiat Res. 1970 Mar;41(3):623–636. [PubMed] [Google Scholar]
  6. Crile G., Jr, Deodhar S. D. Role of preoperative irradiation in prolonging concomitant immunity and preventing metastasis in mice. Cancer. 1971 Mar;27(3):629–634. doi: 10.1002/1097-0142(197103)27:3<629::aid-cncr2820270318>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
  7. Dennert G. Thymus derived killer cells: specificity of function, and antigen recognition. Transplant Rev. 1976;29:59–88. doi: 10.1111/j.1600-065x.1976.tb00197.x. [DOI] [PubMed] [Google Scholar]
  8. Drewinko B., Montgomery C. T., Trujillo J. M. Demonstration of common sarcoma-associated antigen(s) in an established human neurogenic sarcoma cell line. Cancer Res. 1973 Mar;33(3):601–605. [PubMed] [Google Scholar]
  9. Droller M. J., Remington J. S. A role for the macrophage in in vivo and in vitro resistance to murine bladder tumor cell growth. Cancer Res. 1975 Jan;35(1):49–53. [PubMed] [Google Scholar]
  10. Fidler I. J. In vitro studies of cellular-mediated immunostimulation of tumor growth. J Natl Cancer Inst. 1973 May;50(5):1307–1312. doi: 10.1093/jnci/50.5.1307. [DOI] [PubMed] [Google Scholar]
  11. Germain R. N., Williams R. M., Benacerraf B. Specific and nonspecific antitumor immunity. II. Macrophage-mediated nonspecific effector activity induced by BCG and similar agents. J Natl Cancer Inst. 1975 Mar;54(3):709–720. [PubMed] [Google Scholar]
  12. Gershon R. K., Carter R. L., Kondo K. On concomitant immunity in tumour-bearing hamsters. Nature. 1967 Feb 18;213(5077):674–676. doi: 10.1038/213674a0. [DOI] [PubMed] [Google Scholar]
  13. Hellström I., Sjögren H. O., Warner G., Hellström K. E. Blocking of cell-mediated tumor immunity by sera from patients with growing neoplasms. Int J Cancer. 1971 Mar 15;7(2):226–237. doi: 10.1002/ijc.2910070206. [DOI] [PubMed] [Google Scholar]
  14. Hellström K. E., Hellström I. Cellular immunity against tumor antigens. Adv Cancer Res. 1969;12:167–223. doi: 10.1016/s0065-230x(08)60331-0. [DOI] [PubMed] [Google Scholar]
  15. Herberman R. B., Oldham R. K. Problems associated with study of cell-mediated immunity to human tumors by microcytotoxicity assays. J Natl Cancer Inst. 1975 Oct;55(4):749–753. doi: 10.1093/jnci/55.4.749. [DOI] [PubMed] [Google Scholar]
  16. Hibbs J. B., Jr, Lambert L. H., Jr, Remington J. S. In vitro nonimmunologic destruction of cells with abnormal growth characteristics by adjuvant activated macrophages. Proc Soc Exp Biol Med. 1972 Mar;139(3):1049–1052. doi: 10.3181/00379727-139-36295. [DOI] [PubMed] [Google Scholar]
  17. Hibbs J. B., Jr, Lambert L. H., Jr, Remington J. S. Resistance to murine tumors conferred by chronic infection with intracellular protozoa, Toxoplasma gondii and Besnoitia jellisoni. J Infect Dis. 1971 Dec;124(6):587–592. doi: 10.1093/infdis/124.6.587. [DOI] [PubMed] [Google Scholar]
  18. Howard J. C. On the relationship between initiator and effector cells in the response to major tansplantation antigens. Transplant Proc. 1973 Dec;5(4):1451–1456. [PubMed] [Google Scholar]
  19. Howell S. B., Esber E. C., Law L. W. Cellular immunity in mice with simian virus 40-induced mKSA tumors: comparison of three assays of tumor immunity. J Natl Cancer Inst. 1974 Apr;52(4):1361–1363. doi: 10.1093/jnci/52.4.1361. [DOI] [PubMed] [Google Scholar]
  20. In vitro methods in cell-mediated immunity: a progress report. Cell Immunol. 1973 Mar;6(3):331–347. doi: 10.1016/0008-8749(73)90034-8. [DOI] [PubMed] [Google Scholar]
  21. KLEIN G., REVESZ L. Quantitative studies on the multiplication of neoplastic cells in vivo. I. Growth curves of the Ehrlich and MC1M ascites tumors. J Natl Cancer Inst. 1953 Oct;14(2):229–277. doi: 10.1093/jnci/14.2.229. [DOI] [PubMed] [Google Scholar]
  22. Kearney R., Basten A., Nelson D. S. Cellular basis for the immune response to methylcholanthrene-induced tumors in mice. Heterogeneity of effector cells. Int J Cancer. 1975 Mar 15;15(3):438–450. doi: 10.1002/ijc.2910150310. [DOI] [PubMed] [Google Scholar]
  23. Kearney R., Nelson D. S. Concomitant immunity to syngeneic methylcholanthrene-induced tumours in mice. Occurrence and specificity of concomitant immunity. Aust J Exp Biol Med Sci. 1973 Dec;51(6):723–735. doi: 10.1038/icb.1973.70. [DOI] [PubMed] [Google Scholar]
  24. Keller R. Mechanisms by which activated normal macrophages destroy syngeneic rat tumour cells in vitro. Cytokinetics, non-involvement of T lymphocytes, and effect of metabolic inhibitors. Immunology. 1974 Aug;27(2):285–298. [PMC free article] [PubMed] [Google Scholar]
  25. Milas L., Hunter N., Mason K., Withers H. R. Immunological resistance to pulmonary metastases in C3Hf-Bu mice bearing syngeneic fibrosarcoma of different sizes. Cancer Res. 1974 Jan;34(1):61–71. [PubMed] [Google Scholar]
  26. North R. J. Importance of thymus-derived lymphocytes in cell-mediated immunity to infection. Cell Immunol. 1973 Apr;7(1):166–176. doi: 10.1016/0008-8749(73)90193-7. [DOI] [PubMed] [Google Scholar]
  27. North R. J., Kirstein D. P., Tuttle R. L. Subversion of host defense mechanisms by murine tumors. I. A circulating factor that suppresses macrophage-mediated resistance to infection. J Exp Med. 1976 Mar 1;143(3):559–573. doi: 10.1084/jem.143.3.559. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. North R. J., Kirstein D. P., Tuttle R. L. Subversion of host defense mechanisms by murine tumors. II. Counter-influence of concomitant antitumor immunity. J Exp Med. 1976 Mar 1;143(3):574–584. doi: 10.1084/jem.143.3.574. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. North R. J. Nature of "memory" in T-cell-mediated antibacterial immunity: anamnestic production of mediator T cells. Infect Immun. 1975 Oct;12(4):754–760. doi: 10.1128/iai.12.4.754-760.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. OLD L. J., BENACERRAF B., CLARKE D. A., CARSWELL E. A., STOCKERT E. The role of the reticuloendothelial system in the host reaction to neoplasia. Cancer Res. 1961 Oct;21:1281–1300. [PubMed] [Google Scholar]
  31. Prehn R. T., Lappé M. A. An immunostimulation theory of tumor development. Transplant Rev. 1971;7:26–54. doi: 10.1111/j.1600-065x.1971.tb00462.x. [DOI] [PubMed] [Google Scholar]
  32. Proctor J. W., Rudenstam C. M., Alexander P. A preliminary investigation into the role of immunity in modifying the blood- borne spread of chemically induced rat sarcomas. J Natl Cancer Inst. 1974 Dec;53(6):1671–1676. [PubMed] [Google Scholar]
  33. Robinette E. H., Jr, Mardon D. N. Delayed lethal response to Candida albicans infection in mice bearing the Lewis lung carcinoma. J Natl Cancer Inst. 1975 Sep;55(3):731–733. doi: 10.1093/jnci/55.3.731. [DOI] [PubMed] [Google Scholar]
  34. Salky N. K., Di Luzio N. R., Levin A. G., Goldsmith H. S. Phagocytic activity of the reticuloendothelial system in neoplastic disease. J Lab Clin Med. 1967 Sep;70(3):393–403. [PubMed] [Google Scholar]
  35. Simes R. J., Kearney R., Nelson D. S. Role of a non-committed accessory cell in the in vivo suppression of a syngeneic tumour by immune lymphocytes. Immunology. 1975 Aug;29(2):343–351. [PMC free article] [PubMed] [Google Scholar]
  36. Steele G., Jr, Sjögren H. O. Cross-reacting tumor-associated antigen (s) among chemically induced rat colon carcinomas. Cancer Res. 1974 Aug;34(8):1801–1807. [PubMed] [Google Scholar]
  37. Vaage J. Concomitant immunity and specific depression of immunity by residual or reinjected syngeneic tumor tissue. Cancer Res. 1971 Nov;31(11):1655–1662. [PubMed] [Google Scholar]
  38. WINN H. J. Immune mechanisms in homotransplantation. II. Quantitative assay of the immunologic activity of lymphoid cells stimulated by tumor homografts. J Immunol. 1961 Feb;86:228–239. [PubMed] [Google Scholar]
  39. Yuhas J. M., Pazmiño N. H., Wagner E. Development of concomitant immunity in mice bearing the weakly immunogenic line 1 lung carcinoma. Cancer Res. 1975 Jan;35(1):237–241. [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES